Rehabilitation in Patients With Pulmonary Fibrosis

Assessment of Improvement in Functional Status of Patients With Pulmonary Fibrosis After Exercise Rehabilitation Program

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06677047

Enrollment

Registered

2024-11-06

Start date

2025-01-20

Completion date

2025-08-20

Last updated

2024-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rehabilitation

Brief summary

This study aims to explore the effects of exercise rehabilitation on the functional status of patients with pulmonary fibrosis, assessing both physical and psychological dimensions of health. By identifying significant improvements, we can contribute to the development of comprehensive rehabilitation strategies that enhance patient outcomes and foster a better quality of life for those affected by this challenging condition

Detailed description

program is essential for understanding its efficacy. Functional status refers to an individual's ability to perform daily activities and maintain independence, which is particularly important for patients with chronic illnesses like PF. Evaluating changes in functional status not only helps in determining the success of rehabilitation efforts but also provides insights into the overall impact of exercise on patients' quality of life.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* 1\. \*\*Diagnosis of Pulmonary Fibrosis:\*\* * Patients must have a confirmed diagnosis of pulmonary fibrosis, as determined by clinical evaluation and imaging studies (e.g., high-resolution computed tomography). 2\. \*\*Age Range:\*\* * Participants should be adults aged 18 years and older to capture the adult population affected by the disease. 3\. \*\*Stable Clinical Condition:\*\* * Patients must be in a stable clinical condition, defined as no exacerbations or significant changes in treatment for at least four weeks prior to enrollmen

Exclusion criteria

* 1\. \*\*Other Significant Lung Diseases:\*\* * Patients with concurrent respiratory conditions (e.g., chronic obstructive pulmonary disease, asthma, or lung cancer) that could confound the results. 2\. \*\*Acute Exacerbations:\*\* * Individuals experiencing an acute exacerbation of pulmonary fibrosis or any significant respiratory illness within four weeks prior to enrollment. 3\. \*\*Severe Comorbidities:\*\* * Patients with severe cardiovascular disease, uncontrolled hypertension, major neurological disorders, or musculoskeletal problems that would impede participation in exercise. 4\. \*\*Cognitive Impairment:\*\* * Individuals with cognitive impairments that prevent them from understanding the study procedures or following the rehabilitation program.

Design outcomes

Primary

Measure	Time frame	Description
Asses Health-Related Quality of Life:	Baseline	Assessed through validated questionnaires such as the St. George's Respiratory Questionnaire (SGRQ)

Contacts

Primary ContactHend Mohamed Sayed, Doctor

hend.m.saleh@gmail.com01098988712

Backup ContactAhmed mohamed Shadad, Doctor

Shaddad_ahmad@aun.edu.eg0111117930

Outcome results